Join us for a detailed overview of the bioscience capabilities, technologies, and partnering opportunities available at Los Alamos National Laboratory. With a history of significant contributions to the biological sciences, LANL continues to push the boundaries of research and development with the mission of reducing threats to populations, our way of life and the global environment.
Learn about LANL’s Feynman Center for Innovation which serves as a catalyst, facilitator and bridging institution between the technical R&D work and companies, universities, and other entities seeking to leverage these unique research capabilities and facilities. Understand the various mechanisms, agreements, and assistance programs currently available for partnering.
Hannah Mazur, a Business Development Executive at the Feynman Center for Innovation, is our keynote presenter. Hannah manages Feynman’s extensive bioscience portfolio and tech transfer activities. With over 15 years of experience in sales and business development for private laboratories and biopharmaceuticals, including Astra Zeneca and Eurofins Scientific, she is eager to share LANL’s expertise and collaborate with NM bioscience companies.
At the conclusion of Hannah’s presentation, ballots will be distributed to attendees to cast their ballots for NMBio’s board of directors seeking two-year terms. Board members will then meet for their annual meeting.